Matches in SemOpenAlex for { <https://semopenalex.org/work/W2396563743> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2396563743 endingPage "807" @default.
- W2396563743 startingPage "795" @default.
- W2396563743 abstract "Main chemotherapy regimens used to treat adult patients with acute myeloid leukemia (AML) in first or further relapse were reviewed. In retrospective study, second complete remission rates ranged from 30% to 64%, while they ranged from 8% to 89% in prospective trials. The second complete remission rates were closely associated with age and duration of first complete remission. Combination therapies resulted in higher complete remission rates but were associated with higher toxicity. Median duration of second complete remission was < 14 months and overall median survival was < 12 months. The probability of 3-year survival ranged from 8% to 29%. The inhomogeneity of these studies, the differences in dosages and schedules, and the frequent absence of randomisation make it difficult to select the best salvage therapy. No reinduction regimen has so far clearly proven superior. Only stem cell transplantation provided durable remissions for the majority of AML patients after a first relapse. Considering the poor outcomes of patients with AML in first relapse, improved therapies need to be developed. A number of novel agents that include several differentiation agents, enzyme inhibitors, and monoclonal antibodies have been studied to provide improved outcomes for patients with AML who have relapsed. This is the same for acute promyelocytic leukaemia (APL). Arsenic trioxide has shown great promise for the induction, consolidation, and maintenance of complete remission in relapsed patients with APL. Within this context autologous and allogeneic bone marrow transplantations are also considered in second or subsequent relapse. Molecular monitoring for the PML-RARalpha fusion protein permits prompt intervention for early molecular relapse ultimately improving chances of prolonged remission." @default.
- W2396563743 created "2016-06-24" @default.
- W2396563743 creator A5072721892 @default.
- W2396563743 creator A5087870886 @default.
- W2396563743 date "2002-09-01" @default.
- W2396563743 modified "2023-10-14" @default.
- W2396563743 title "[Treatment of acute myeloid leukemias in the adult in relapse]." @default.
- W2396563743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12368132" @default.
- W2396563743 hasPublicationYear "2002" @default.
- W2396563743 type Work @default.
- W2396563743 sameAs 2396563743 @default.
- W2396563743 citedByCount "0" @default.
- W2396563743 crossrefType "journal-article" @default.
- W2396563743 hasAuthorship W2396563743A5072721892 @default.
- W2396563743 hasAuthorship W2396563743A5087870886 @default.
- W2396563743 hasConcept C104317684 @default.
- W2396563743 hasConcept C126322002 @default.
- W2396563743 hasConcept C141071460 @default.
- W2396563743 hasConcept C143998085 @default.
- W2396563743 hasConcept C151730666 @default.
- W2396563743 hasConcept C185592680 @default.
- W2396563743 hasConcept C2776601000 @default.
- W2396563743 hasConcept C2776694085 @default.
- W2396563743 hasConcept C2778336483 @default.
- W2396563743 hasConcept C2778729363 @default.
- W2396563743 hasConcept C2779343474 @default.
- W2396563743 hasConcept C2780775027 @default.
- W2396563743 hasConcept C2781121885 @default.
- W2396563743 hasConcept C2781413609 @default.
- W2396563743 hasConcept C55493867 @default.
- W2396563743 hasConcept C71924100 @default.
- W2396563743 hasConcept C86803240 @default.
- W2396563743 hasConceptScore W2396563743C104317684 @default.
- W2396563743 hasConceptScore W2396563743C126322002 @default.
- W2396563743 hasConceptScore W2396563743C141071460 @default.
- W2396563743 hasConceptScore W2396563743C143998085 @default.
- W2396563743 hasConceptScore W2396563743C151730666 @default.
- W2396563743 hasConceptScore W2396563743C185592680 @default.
- W2396563743 hasConceptScore W2396563743C2776601000 @default.
- W2396563743 hasConceptScore W2396563743C2776694085 @default.
- W2396563743 hasConceptScore W2396563743C2778336483 @default.
- W2396563743 hasConceptScore W2396563743C2778729363 @default.
- W2396563743 hasConceptScore W2396563743C2779343474 @default.
- W2396563743 hasConceptScore W2396563743C2780775027 @default.
- W2396563743 hasConceptScore W2396563743C2781121885 @default.
- W2396563743 hasConceptScore W2396563743C2781413609 @default.
- W2396563743 hasConceptScore W2396563743C55493867 @default.
- W2396563743 hasConceptScore W2396563743C71924100 @default.
- W2396563743 hasConceptScore W2396563743C86803240 @default.
- W2396563743 hasIssue "9" @default.
- W2396563743 hasLocation W23965637431 @default.
- W2396563743 hasOpenAccess W2396563743 @default.
- W2396563743 hasPrimaryLocation W23965637431 @default.
- W2396563743 hasRelatedWork W123058966 @default.
- W2396563743 hasRelatedWork W1883984906 @default.
- W2396563743 hasRelatedWork W2146712309 @default.
- W2396563743 hasRelatedWork W2413521266 @default.
- W2396563743 hasRelatedWork W2550690808 @default.
- W2396563743 hasRelatedWork W2912762483 @default.
- W2396563743 hasRelatedWork W2981686895 @default.
- W2396563743 hasRelatedWork W2998307583 @default.
- W2396563743 hasRelatedWork W3031742001 @default.
- W2396563743 hasRelatedWork W91423968 @default.
- W2396563743 hasVolume "89" @default.
- W2396563743 isParatext "false" @default.
- W2396563743 isRetracted "false" @default.
- W2396563743 magId "2396563743" @default.
- W2396563743 workType "article" @default.